Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.275
-0.035 (-1.52%)
May 28, 2026, 2:43 PM EDT - Market open

BDTX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
-70----
Gross Profit
-70----
Selling, General & Admin
15.8616.5727.4727.1128.3930.04
Research & Development
30.0633.5651.3159.3564.4496.83
Other Operating Expenses
7.357.35----
Total Operating Expenses
53.2757.4878.7886.4692.83126.87
Operating Income
-53.2712.52-78.78-86.46-92.83-126.87
Total Non-Operating Income (Expense)
10.069.859.114.023.911.28
Pretax Income
-43.2122.37-69.68-82.44-88.92-125.6
Net Income
-43.2122.37-69.68-82.44-91.17-125.6
Net Income to Common
-43.2122.37-69.68-82.44-91.17-125.6
Shares Outstanding (Basic)
575755443636
Shares Outstanding (Diluted)
575855443636
Shares Change (YoY)
0.94%4.61%25.19%21.00%0.38%9.97%
EPS (Basic)
-0.770.39-1.27-1.88-2.52-3.47
EPS (Diluted)
-0.770.39-1.27-1.88-2.52-3.47
Shares Outstanding
57.357.1456.6451.6536.4336.23
Free Cash Flow
-34.0329.61-62.3-66.75-85.27-102.86
Free Cash Flow Per Share
-0.600.51-1.13-1.52-2.35-2.84
Gross Margin
-100.00%----
Operating Margin
-17.89%----
Profit Margin
-31.95%----
FCF Margin
-42.31%----
EBITDA
-54.0311.57-82.22-87.2-91.78-124.48
EBITDA Margin
-16.53%----
EBIT
-53.2712.52-78.78-86.46-92.83-126.87
EBIT Margin
-17.89%----
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q